Nanome develops collaborative and immersive tools for enterprise drug discovery. Nanome’s software is used by early stage R&D teams from pharmaceutical and biotechnology companies to develop new drugs. The software has native collaboration and integrates with 3rd party simulation software. Nanome has published a paper with Novartis GNF in the journal of molecular modelling.
Company Info:
Year Founded:2015
Founders:Sam Hessenauer, Steve McCloskey, Keita Funakawa, Edgardo Leija
CEO(s)/CTO(s)/Other Officers:Steve McCloskey CEO, Sam Hessenauer Chief Engineer, Keita Funakawa COO
Investors:Colopl Next, HTC, angels
Company Size:11 to 20
Stage:Seed (must be over 1M)
Log in with your credentials
Don't have an account yet?
Create an account
Forgot your details?
© 2020 Charlie Fink